Stock Chart

MURA

$2.03 0.00%
Score: 53.2 BUY
Pro
Screener
Vol: 0.13x (vs SPY: 0.4x | vs QQQ: 0.2x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Chart Pattern · as of Dec 04, 2025
Bear Flag Bearish scenario quality 97/100
Setup invalidates on a close above $2.04 · pole −32% — no price target (measured-move targets failed our backtest for flags/pennants)
Historically breaks down 69% of the time (n=379) — the only flag with real bearish follow-through. Measured-move targets failed our backtest — none shown.
Pattern detection is automated and probabilistic — a scenario map for levels, not a buy/sell signal. Rails, projected path and invalidation level are drawn on the chart below.
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About MURA - Mural Oncology plc Ordinary Shares

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the …

Key Statistics

Market Cap $35M

This MURA stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track MURA's price movements with trendlines, gamma walls, and key support/resistance levels.